Skip to content

Vericel VCEL Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Stryker logo
StrykerSYK
-$654M-29.8%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
-$3.08M-334%
Globus Medical logo
Globus MedicalGMED
-$24.67M+13.9%

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's change in accrued liabilities?
Vericel (VCEL) reported change in accrued liabilities of -$5.27M in Q1 2026.
How has Vericel's change in accrued liabilities changed year-over-year?
Vericel's change in accrued liabilities increased by 7.9% year-over-year, from -$5.72M to -$5.27M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.